The common heartburn medication Pepcid is in short supply across Canada, and experts say it's a direct result of the recent international recall of Zantac. Zantac, or ranitidine, was recalled in ...

Those who used ranitidine compared with famotidine were more likely to have a diagnosis of GERD. Overall, the incidence of cancer with ranitidine was 26.4% vs. 31.1% with famotidine and 13% in the ...

The agency tested samples of over-the-counter alternatives such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec and found no NDMA. The agency's investigation of ranitidine seeks to uncover ...

Amidst recent recalls over a suspected carcinogen used in the over-the-counter acid reflux medication Zantac, the Food and ... including the likes of Pepcid (famotidine), Tagamet (cimetidine ...

Sanofi has since returned Zantac to store shelves but without ranitidine. It is now made with famotidine, the active ingredient in competitor Pepcid.

such as famotidine or Pepcid, esomeprazole or Nexium, or omeprazole or Prilosec. For patients taking prescription ranitidine, the FDA said to talk to your doctor about other treatment options ...

Proton pump inhibitors, such as Prilosec, Prevacid and Nexium, or so-called H2 blockers, such as Zantac, Pepcid and Tagamet, were linked to a 50 percent increased risk of developing multiple ...

Sanofi has since returned Zantac to store shelves, but without ranitidine. It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is the third leading antacid sold in ...

What Jill Goldstein discovered was that her nearly two-decade-long use of the over-the-counter and prescription drug Zantac to combat ... medicine such as Pepcid, Tagamet, Nexium, Prevacid or ...

like Pepcid, Tagamet, Nexium, Prevacid and Prilosec, have shown no NDMA impurities in the medicines, according to Woodcock’s statement. If you take prescription ranitidine or nizatidine ...

but without ranitidine. It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is still one of the US’s leading heartburn treatments in a market that generated $14 ...